- Report
- March 2024
- 86 Pages
Global
From €6676EUR$6,995USD£5,593GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- May 2024
- 119 Pages
Global
From €1861EUR$1,950USD£1,559GBP
- Report
- January 2025
- 191 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- May 2024
- 277 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- January 2025
Global
From €3770EUR$3,950USD£3,159GBP
- Newsletter
- March 2025
Global
€2858EUR$2,995USD£2,395GBP
- Report
- February 2025
- 225 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$5,601USD£4,327GBP
- Report
- July 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2024
- 250 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- May 2024
- 90 Pages
United States
From €3770EUR$3,950USD£3,159GBP
- Report
- September 2024
- 94 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Report
- September 2024
- 90 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- September 2024
- 94 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- August 2024
- 125 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- October 2024
- 151 Pages
North America
From €3293EUR$3,450USD£2,759GBP
- Database
- March 2025
Global
From €286EUR$300USD£240GBP
- Report
- July 2022
- 263 Pages
Global
From €1800EUR$2,020USD£1,561GBP
- Report
- December 2022
- 363 Pages
Global
From €4580EUR$4,799USD£3,837GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more